Psychotropic drug use in Northern Ireland 1966-80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables - PubMed (original) (raw)
Comparative Study
Psychotropic drug use in Northern Ireland 1966-80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables
D J King et al. Psychol Med. 1982 Nov.
Abstract
A study of psychotropic drug prescribing, derived from the computerized pricing data in Northern Ireland from 1966, showed that the use of these drugs reached a peak in 1975, when about 12.5% of the adult population were estimated to have been receiving them, and declined in the following 5 years. Benzodioazepines accounted for three-quarters of all psychotropic drugs prescribed in 1980. Benzodiazepine tranquillizer prescribing was consistently 20-30% higher than in the rest of the United Kingdom, in contrast to hypnotic and antidepressant prescribing which has been consistently lower. The rate of increase in benzodiazepine tranquillizer prescribing was greater than in other European countries, but the level remains lower than in Iceland and Denmark. The influence of a number of demographic and socioeconomic variables was studied in an intra-regional analysis of the 1978 data for the 17 health districts in the province, using multivariate and multiple regression statistics. The prescribing of benzodiazepine hypnotics was almost entirely accounted for by the proportion of elderly (over 65 years) and women aged 45-59 years: neuroleptic prescribing was largely a function of factors associated with rural areas (overcrowding and unemployment) and the proportion of elderly; but neither tranquillizer, antidepressant, barbiturate hypnotic nor psychostimulant prescribing were satisfactorily explained by these variables.
Similar articles
- Patterns in drug utilization--national and international aspects: psychoactive drugs 1966-80.
King DJ, Griffiths K. King DJ, et al. Acta Med Scand Suppl. 1984;683:71-7. doi: 10.1111/j.0954-6820.1984.tb08719.x. Acta Med Scand Suppl. 1984. PMID: 6146250 - Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices.
Pharoah PD, Melzer D. Pharoah PD, et al. Br J Gen Pract. 1995 Nov;45(400):595-9. Br J Gen Pract. 1995. PMID: 8554839 Free PMC article. - Differences in prescribing psychotropic drugs for elderly with depression.
Huang YC, Wang LJ, Chong MY. Huang YC, et al. Acta Neuropsychiatr. 2016 Oct;28(5):296-303. doi: 10.1017/neu.2016.4. Epub 2016 Feb 22. Acta Neuropsychiatr. 2016. PMID: 26899461 - Rational use of psychotropic drugs. II. Antianxiety agents.
Greenblatt DJ, Shader RI. Greenblatt DJ, et al. J Maine Med Assoc. 1974 Sep;65(9):225-9. J Maine Med Assoc. 1974. PMID: 4153460 Review. No abstract available. - Drug therapy: Psychotropic drug use in the elderly (first of two parts).
Thompson TL 2nd, Moran MG, Nies AS. Thompson TL 2nd, et al. N Engl J Med. 1983 Jan 20;308(3):134-8. doi: 10.1056/NEJM198301203080305. N Engl J Med. 1983. PMID: 6129573 Review. No abstract available.
Cited by
- Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020.
Højlund M, Gudmundsson LS, Andersen JH, Saastamoinen LK, Zoega H, Skurtveit SO, Wastesson JW, Hallas J, Pottegård A. Højlund M, et al. Basic Clin Pharmacol Toxicol. 2023 Jan;132(1):60-70. doi: 10.1111/bcpt.13811. Epub 2022 Nov 8. Basic Clin Pharmacol Toxicol. 2023. PMID: 36314353 Free PMC article. - Potentially inappropriate prescribing among older people in the United Kingdom.
Bradley MC, Motterlini N, Padmanabhan S, Cahir C, Williams T, Fahey T, Hughes CM. Bradley MC, et al. BMC Geriatr. 2014 Jun 12;14:72. doi: 10.1186/1471-2318-14-72. BMC Geriatr. 2014. PMID: 24919523 Free PMC article. - Doctors' knowledge of post traumatic neurosis.
Daly O. Daly O. Ulster Med J. 1997 May;66(1):28-33. Ulster Med J. 1997. PMID: 9185487 Free PMC article. - Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community.
Ekedahl A, Lidbeck J, Lithman T, Noreen D, Melander A. Ekedahl A, et al. Eur J Clin Pharmacol. 1993;44(2):141-6. doi: 10.1007/BF00315471. Eur J Clin Pharmacol. 1993. PMID: 8095896